Last reviewed · How we verify
Patients on atorvastatin treatment
At a glance
| Generic name | Patients on atorvastatin treatment |
|---|---|
| Sponsor | Elpen Pharmaceutical Co. Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Atorvastatin Therapy on Xanthoma in Alagille Syndrome (PHASE4)
- A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events (PHASE3)
- Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients (PHASE3)
- Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study) (NA)
- A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
- Vascular Endothelial Dysfunction in Sleep Apnea (PHASE1)
- Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis (PHASE2)
- Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Patients on atorvastatin treatment CI brief — competitive landscape report
- Patients on atorvastatin treatment updates RSS · CI watch RSS
- Elpen Pharmaceutical Co. Inc. portfolio CI